跳至主要内容
临床试验/NCT01934920
NCT01934920Unknown不适用

Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

Elman Retina Group2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Assess the incidence of new and/or undiagnosed diabetic macular edema.

研究概览

简要总结

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study
  • Age > 18 years
  • Patient related considerations
  • Patients with diabetes mellitus
  • Disease related considerations
  • Diabetes mellitus

排除标准

  • Prior admission screening within twelve months.
  • Inability to sit for evaluation

结局指标

主要结局

Assess the incidence of new and/or undiagnosed diabetic macular edema.

时间窗: 1 day (Patients are only seen once for assessments)

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

次要结局

  • Streamlining and identification of patients at risk of diabetic macular edema(1 day (Patients only seen once for assessments))

研究者

发起方
Elman Retina Group
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验